148 related articles for article (PubMed ID: 34550600)
1. The molecular structure and role of LECT2 or CHM-II in arthritis, cancer, and other diseases.
Zhu S; Bennett S; Li Y; Liu M; Xu J
J Cell Physiol; 2022 Jan; 237(1):480-488. PubMed ID: 34550600
[TBL] [Abstract][Full Text] [Related]
2. The emerging roles of leukocyte cell-derived chemotaxin-2 in immune diseases: From mechanisms to therapeutic potential.
Zhu MH; Liu YJ; Li CY; Tao F; Yang GJ; Chen J
Front Immunol; 2023; 14():1158083. PubMed ID: 36969200
[TBL] [Abstract][Full Text] [Related]
3. LECT2, a Ligand for Tie1, Plays a Crucial Role in Liver Fibrogenesis.
Xu M; Xu HH; Lin Y; Sun X; Wang LJ; Fang ZP; Su XH; Liang XJ; Hu Y; Liu ZM; Cheng Y; Wei Y; Li J; Li L; Liu HJ; Cheng Z; Tang N; Peng C; Li T; Liu T; Qiao L; Wu D; Ding YQ; Zhou WJ
Cell; 2019 Sep; 178(6):1478-1492.e20. PubMed ID: 31474362
[TBL] [Abstract][Full Text] [Related]
4. LECT2 as a hepatokine links liver steatosis to inflammation via activating tissue macrophages in NASH.
Takata N; Ishii KA; Takayama H; Nagashimada M; Kamoshita K; Tanaka T; Kikuchi A; Takeshita Y; Matsumoto Y; Ota T; Yamamoto Y; Yamagoe S; Seki A; Sakai Y; Kaneko S; Takamura T
Sci Rep; 2021 Jan; 11(1):555. PubMed ID: 33436955
[TBL] [Abstract][Full Text] [Related]
5. Leukocyte Cell-Derived Chemotaxin 2 Retards Non-Small Cell Lung Cancer Progression Through Antagonizing MET and EGFR Activities.
Hung WY; Chang JH; Cheng Y; Chen CK; Chen JQ; Hua KT; Cheng CW; Hsiao M; Chung CL; Lee WJ; Chien MH
Cell Physiol Biochem; 2018; 51(1):337-355. PubMed ID: 30453282
[TBL] [Abstract][Full Text] [Related]
6. LECT2: A pleiotropic and promising hepatokine, from bench to bedside.
Xie Y; Fan KW; Guan SX; Hu Y; Gao Y; Zhou WJ
J Cell Mol Med; 2022 Jul; 26(13):3598-3607. PubMed ID: 35656863
[TBL] [Abstract][Full Text] [Related]
7. LECT2 induces atherosclerotic inflammatory reaction via CD209 receptor-mediated JNK phosphorylation in human endothelial cells.
Hwang HJ; Jung TW; Hong HC; Seo JA; Kim SG; Kim NH; Choi KM; Choi DS; Baik SH; Yoo HJ
Metabolism; 2015 Sep; 64(9):1175-82. PubMed ID: 26123523
[TBL] [Abstract][Full Text] [Related]
8. LECT2 functions as a hepatokine that links obesity to skeletal muscle insulin resistance.
Lan F; Misu H; Chikamoto K; Takayama H; Kikuchi A; Mohri K; Takata N; Hayashi H; Matsuzawa-Nagata N; Takeshita Y; Noda H; Matsumoto Y; Ota T; Nagano T; Nakagen M; Miyamoto K; Takatsuki K; Seo T; Iwayama K; Tokuyama K; Matsugo S; Tang H; Saito Y; Yamagoe S; Kaneko S; Takamura T
Diabetes; 2014 May; 63(5):1649-64. PubMed ID: 24478397
[TBL] [Abstract][Full Text] [Related]
9. A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression.
Hwang HJ; Jung TW; Kim BH; Hong HC; Seo JA; Kim SG; Kim NH; Choi KM; Choi DS; Baik SH; Yoo HJ
Biochem Pharmacol; 2015 Nov; 98(1):157-66. PubMed ID: 26297911
[TBL] [Abstract][Full Text] [Related]
10. Role of leukocyte cell-derived chemotaxin 2 as a biomarker in hepatocellular carcinoma.
Okabe H; Delgado E; Lee JM; Yang J; Kinoshita H; Hayashi H; Tsung A; Behari J; Beppu T; Baba H; Monga SP
PLoS One; 2014; 9(6):e98817. PubMed ID: 24892551
[TBL] [Abstract][Full Text] [Related]
11. Suppressive role of leukocyte cell-derived chemotaxin 2 in mouse anti-type II collagen antibody-induced arthritis.
Okumura A; Saito T; Otani I; Kojima K; Yamada Y; Ishida-Okawara A; Nakazato K; Asano M; Kanayama K; Iwakura Y; Suzuki K; Yamagoe S
Arthritis Rheum; 2008 Feb; 58(2):413-21. PubMed ID: 18240267
[TBL] [Abstract][Full Text] [Related]
12. Loss of LECT2 promotes ovarian cancer progression by inducing cancer invasiveness and facilitating an immunosuppressive environment.
Wu CJ; Pan KF; Chen JQ; Tao Y-; Liu YC; Chen BR; Hsu C; Wang MY; Sheu BC; Hsiao M; Hua KT; Wei LH
Oncogene; 2024 Feb; 43(7):511-523. PubMed ID: 38177412
[TBL] [Abstract][Full Text] [Related]
13. Expression, high-pressure refolding and purification of human leukocyte cell-derived chemotaxin 2 (LECT2).
Zheng H; Miyakawa T; Sawano Y; Yamagoe S; Tanokura M
Protein Expr Purif; 2013 Apr; 88(2):221-9. PubMed ID: 23337084
[TBL] [Abstract][Full Text] [Related]
14. Crystal Structure of Human Leukocyte Cell-derived Chemotaxin 2 (LECT2) Reveals a Mechanistic Basis of Functional Evolution in a Mammalian Protein with an M23 Metalloendopeptidase Fold.
Zheng H; Miyakawa T; Sawano Y; Asano A; Okumura A; Yamagoe S; Tanokura M
J Biol Chem; 2016 Aug; 291(33):17133-42. PubMed ID: 27334921
[TBL] [Abstract][Full Text] [Related]
15. Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver.
Ovejero C; Cavard C; Périanin A; Hakvoort T; Vermeulen J; Godard C; Fabre M; Chafey P; Suzuki K; Romagnolo B; Yamagoe S; Perret C
Hepatology; 2004 Jul; 40(1):167-76. PubMed ID: 15239100
[TBL] [Abstract][Full Text] [Related]
16. The tumor suppressor function of LECT2 in human hepatocellular carcinoma makes it a potential therapeutic target.
Ong HT; Tan PK; Wang SM; Hian Low DT; Ooi LL; Hui KM
Cancer Gene Ther; 2011 Jun; 18(6):399-406. PubMed ID: 21394108
[TBL] [Abstract][Full Text] [Related]
17. LECT2 association with macrophage-mediated killing of Helicobacter pylori by activating NF-κB and nitric oxide production.
Shen HX; Li L; Chen Q; He YQ; Yu CH; Chu CQ; Lu XJ; Chen J
Genet Mol Res; 2016 Oct; 15(4):. PubMed ID: 27813598
[TBL] [Abstract][Full Text] [Related]
18. LECT2 protects mice against bacterial sepsis by activating macrophages via the CD209a receptor.
Lu XJ; Chen J; Yu CH; Shi YH; He YQ; Zhang RC; Huang ZA; Lv JN; Zhang S; Xu L
J Exp Med; 2013 Jan; 210(1):5-13. PubMed ID: 23254286
[TBL] [Abstract][Full Text] [Related]
19. Leukocyte cell-derived chemotaxin 2 antagonizes MET receptor activation to suppress hepatocellular carcinoma vascular invasion by protein tyrosine phosphatase 1B recruitment.
Chen CK; Yang CY; Hua KT; Ho MC; Johansson G; Jeng YM; Chen CN; Chen MW; Lee WJ; Su JL; Lai TC; Chou CC; Ho BC; Chang CF; Lee PH; Chang KJ; Hsiao M; Lin MT; Kuo ML
Hepatology; 2014 Mar; 59(3):974-85. PubMed ID: 24114941
[TBL] [Abstract][Full Text] [Related]
20. LECT 2 Antagonizes FOXM1 Signaling via Inhibiting MET to Retard PDAC Progression.
Li X; Lin P; Tao Y; Jiang X; Li T; Wang Y; Wang C; Cao Y
Front Cell Dev Biol; 2021; 9():661122. PubMed ID: 33937262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
